Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|May 14, 2026
Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17Shuixian Du, Xueru Chu, Shousheng Liu, et al.
Gastroenterology Research and Practice|November 30, 2019
Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han PopulationYingyu Xu, Zhenzhen Zhao, Shousheng Liu, et al.
Experimental and Therapeutic Medicine|December 4, 2020
Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review)Qing Zhang, Shousheng Liu, Jie Zhang, et al.
Journal of Clinical and Translational Hepatology|August 27, 2021
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisDongli Han, Jie Chen, Shousheng Liu, et al.
BMC Gastroenterology|June 22, 2022
Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han populationDongli Han, Haiying Zhang, Shousheng Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2020
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19Mengzhen Dong, Jie Zhang, Xuefeng Ma, et al.
Experimental and Therapeutic Medicine|August 15, 2019
Role and effective therapeutic target of gut microbiota in NAFLD/NASHQun Liu, Shousheng Liu, Lizhen Chen, et al.
Journal of Clinical and Translational Hepatology|July 12, 2019
Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han PopulationYuan Li, Shousheng Liu, Yuqiang Gao, et al.
Pageof 9